MCM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.059800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.206800E-01
Normal-vs-Stage2
9.801600E-01
Normal-vs-Stage3
4.019600E-01
Normal-vs-Stage4
7.801800E-01
Stage1-vs-Stage2
3.231600E-02
Stage1-vs-Stage3
8.396200E-01
Stage1-vs-Stage4
3.735200E-01
Stage2-vs-Stage3
3.276400E-01
Stage2-vs-Stage4
7.563000E-01
Stage3-vs-Stage4
4.225400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.388400E-01
Normal-vs-AfricanAmerican
7.525400E-01
Normal-vs-Asian
7.114200E-01
Caucasian-vs-AfricanAmerican
7.131600E-01
Caucasian-vs-Asian
1.837220E-01
AfricanAmerican-vs-Asian
9.086400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.785800E-01
Normal-vs-Female
9.503800E-01
Male-vs-Female
7.072200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.096200E-01
Normal-vs-Age(41-60Yrs)
9.996800E-01
Normal-vs-Age(61-80Yrs)
8.255000E-01
Normal-vs-Age(81-100Yrs)
7.664400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.140800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.924000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.177200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.049400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.430600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.341000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.307800E-01
Normal-vs-Daily Drinker
8.495400E-01
Normal-vs-Weekly Drinker
9.464600E-01
Normal-vs-Occasional Drinker
7.105600E-01
Normal-vs-Social Drinker
9.516200E-01
Non Drinker-vs-Daily Drinker
9.327400E-01
Non Drinker-vs-Weekly Drinker
6.148200E-01
Non Drinker-vs-Occasional Drinker
2.012800E-01
Non Drinker-vs-Social Drinker
6.083800E-01
Daily Drinker-vs-Weekly Drinker
7.018400E-01
Daily Drinker-vs-Occasional Drinker
2.713200E-01
Daily Drinker-vs-Social Drinker
6.618200E-01
Weekly Drinker-vs-Occasional Drinker
6.075400E-01
Weekly Drinker-vs-Social Drinker
9.786200E-01
Occasional Drinker-vs-Social Drinker
5.569000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.936000E-01
Normal-vs-Grade 2
6.576600E-01
Normal-vs-Grade 3
7.467600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.577130E-03
Grade 1-vs-Grade 3
2.41559999999419E-05
Grade 1-vs-Grade 4
5.936000E-01
Grade 2-vs-Grade 3
1.312030E-02
Grade 2-vs-Grade 4
6.576600E-01
Grade 3-vs-Grade 4
7.467600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.062600E-01
Normal-vs-NonDiabetic
9.693200E-01
Diabetic-vs-NonDiabetic
5.564400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.864800E-01
Normal-vs-NoPancreatitis
9.293000E-01
Pancreatitis-vs-NoPancreatitis
4.471200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.711600E-01
Normal-vs-N1
9.597200E-01
N0-vs-N1
7.471000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.851400E-01
Normal-vs-TP53-NonMutant
4.587800E-01
TP53-Mutant-vs-TP53-NonMutant
4.89409999970825E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
